MLYS Shares Calculator
Enter either the number of shares you'd like to purchase OR the total investment you'd like to make.
shares x $13.52 = $135.2
MLYS Prices
View the MLYS historical prices.
52WL $5.85
The 52 Week Low is $5.85 set on Wed, Nov 22, 2023.
52WH $17.44
The 52 Week High is $17.44 set on Wed, Mar 8, 2023. The current price, $13.52, is 0% below the 52 Week High.
ATH $19.32
The All-Time High is $19.32 set on Fri, Mar 3, 2023. The current price, $13.52, is 0% below the All Time High.
52 Week Range
MLYS Dividends
MLYS has no dividend history.
0.00%
Annual Dividend Yield
$
Quarterly Dividend Rate
--
Declaration Date
--
Ex-Dividend Date
--
Record Date
--
Payment Date
--
Dividend Frequency
0
Dividend History
MLYS Profile
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.
